000 | 01926 a2200517 4500 | ||
---|---|---|---|
005 | 20250513122804.0 | ||
264 | 0 | _c19970902 | |
008 | 199709s 0 0 eng d | ||
022 | _a0268-3369 | ||
024 | 7 |
_a10.1038/sj.bmt.1700843 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChan, C Y | |
245 | 0 | 0 |
_aAntibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT). _h[electronic resource] |
260 |
_bBone marrow transplantation _cJul 1997 |
||
300 |
_a33-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntibodies, Bacterial _xblood |
650 | 0 | 4 |
_aBacterial Infections _xprevention & control |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHaemophilus Vaccines _xadministration & dosage |
650 | 0 | 4 |
_aHaemophilus influenzae _ximmunology |
650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
650 | 0 | 4 |
_aHodgkin Disease _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin G _xblood |
650 | 0 | 4 |
_aImmunosuppression Therapy _xadverse effects |
650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aTetanus Toxoid _xadministration & dosage |
650 | 0 | 4 | _aTransplantation, Autologous |
650 | 0 | 4 |
_aVaccines, Conjugate _xadministration & dosage |
700 | 1 | _aMolrine, D C | |
700 | 1 | _aAntin, J H | |
700 | 1 | _aWheeler, C | |
700 | 1 | _aGuinan, E C | |
700 | 1 | _aWeinstein, H J | |
700 | 1 | _aPhillips, N R | |
700 | 1 | _aMcGarigle, C | |
700 | 1 | _aHarvey, S | |
700 | 1 | _aSchnipper, C | |
700 | 1 | _aAmbrosino, D M | |
773 | 0 |
_tBone marrow transplantation _gvol. 20 _gno. 1 _gp. 33-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1700843 _zAvailable from publisher's website |
999 |
_c9212443 _d9212443 |